期刊
NEPHRON
卷 144, 期 5, 页码 245-247出版社
KARGER
DOI: 10.1159/000507261
关键词
Coronavirus disease 2019; End-stage kidney disease; Dialysis; Continuous renal replacement therapy
资金
- National Natural Science Foundation [81700579]
- Shanghai science and technology talent program [19YF1450300]
- National Social Science Fund of China [17AGL024]
- general scientific research project of Huoshenshan hospital [140]
Since December 2019, the epidemic of coronavirus disease 2019 (COVID-19) has spread very rapidly in China and worldwide. In this article, we report on a 75-year-old man infected with 2019 novel coronavirus who has end-stage kidney disease (ESKD). COVID-19 patients with ESKD need isolation dialysis, but most of them cannot be handled in time due to limited continuous renal replacement therapy (CRRT) machines. CRRT provided benefits for this patient by removing potentially damaging toxins and stabilizing his metabolic and hemodynamic status. With the control of uremia and fluid status, this patient ended up with an uneventful post-CRRT course, absence of clinical symptoms, and negative PCR tests. Greater efforts are needed to decrease the mortality of COVID-19-infected ESKD patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据